Aerogen Pharma and Lyomark Pharma partner to develop inhaled surfactant, begin a Phase 2 clinical trial

GALWAY, IRELAND & OBERHACHING, GERMANY – DECEMBER 7, 2017: Aerogen Pharma, a developer of innovative inhaled treatments for patients in critical care, and Lyomark Pharma, an established provider of high-quality medicines for the hospital market, are joining forces to develop a clinically superior treatment for Respiratory Distress Syndrome (RDS), a life-threatening condition of preterm infants … Read more

Lyomark Pharma GmbH become majority shareholder of Lyocontract GmbH

We are pleased to announce that effective August 1st 2017 Lyomark Pharma GmbH shall become majority shareholder of Lyocontract GmbH. This will expand our combined capabilities and strengthen our overall position in the pharmaceutical industry. Lyocontract is a state-of-the-art pharmaceutical manufacturing site with the capabilities of producing liquid and freeze-dried parenteral drugs in vials. The … Read more